{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T15:48:18Z","timestamp":1784389698185,"version":"3.55.0"},"reference-count":51,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T00:00:00Z","timestamp":1750723200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006955","name":"Office of Extramural Research, National Institutes of Health","doi-asserted-by":"publisher","award":["1U19NS132296-01"],"award-info":[{"award-number":["1U19NS132296-01"]}],"id":[{"id":"10.13039\/100006955","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006955","name":"Office of Extramural Research, National Institutes of Health","doi-asserted-by":"publisher","award":["U19NS132296"],"award-info":[{"award-number":["U19NS132296"]}],"id":[{"id":"10.13039\/100006955","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>Genetic medicines, including CRISPR\/Cas technologies, extend tremendous promise for addressing unmet medical need in inherited retinal disorders and other indications; however, there remain challenges for the development of therapeutics. Herein, we evaluate genome editing by engineered Cas9 ribonucleoproteins (eRNP) in vivo via subretinal administration using mouse and pig animal models. Subretinal administration of adenine base editor and double strand break-inducing Cas9 nuclease eRNPs mediate genome editing in both species. Editing occurs in retinal pigmented epithelium (RPE) and photoreceptor cells, with favorable tolerability in both species. Using transgenic reporter strains, we determine that editing primarily occurs close to the site of administration, within the bleb region associated with subretinal injection. Our results show that subretinal administration of BE-eRNPs in mice mediates base editing of up to 12% of the total neural retina, with an average rate of 7% observed at the highest dose tested. In contrast, a substantially lower editing efficiency was observed in minipigs; even with direct quantification of only the treated region, a maximum base editing rate of 1.5%, with an average rate of &lt;1%, was observed. Our data highlight the importance of species consideration in preclinical studies for the development of genetic medicines targeting the eye and provide an example of a lack of translation between small and larger animal models in the context of subretinal administration of Cas9 eRNPs.<\/jats:p>","DOI":"10.1371\/journal.pone.0317387","type":"journal-article","created":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T13:45:20Z","timestamp":1750772720000},"page":"e0317387","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evaluation of subretinally delivered Cas9 ribonucleoproteins in murine and porcine animal models highlights key considerations for therapeutic translation of genetic medicines"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9673-9683","authenticated-orcid":true,"given":"Spencer C.","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2158-6253","authenticated-orcid":true,"given":"Aaron J.","family":"Cantor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Walleshauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rina","family":"Mepani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kory","family":"Melton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashil","family":"Bans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prachi","family":"Khekare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suhani","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8155-4247","authenticated-orcid":true,"given":"Craig","family":"Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radwan","family":"Kiwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"McCawley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vihasi","family":"Jani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weng In","family":"Leong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawan K.","family":"Shahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Boivin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Otoupal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bikash R.","family":"Pattnaik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Gamm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2837-0858","authenticated-orcid":true,"given":"Krishanu","family":"Saha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin G.","family":"Gowen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Haak-Frendscho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary J.","family":"Janatpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam P.","family":"Silverman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,6,24]]},"reference":[{"key":"pone.0317387.ref001","doi-asserted-by":"crossref","DOI":"10.3389\/fgeed.2024.1342193","article-title":"Revolutionizing in vivo therapy with CRISPR\/Cas genome editing: breakthroughs, opportunities and challenges","volume":"6","author":"A Macarr\u00f3n Palacios","year":"2024","journal-title":"Front Genome Ed"},{"key":"pone.0317387.ref002","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1016\/j.cell.2022.03.045","article-title":"Therapeutic in vivo delivery of gene editing agents","volume":"185","author":"A Raguram","year":"2022","journal-title":"Cell"},{"key":"pone.0317387.ref003","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jconrel.2022.01.013","article-title":"Delivery of CRISPR-Cas tools for in vivo genome editing therapy: trends and challenges","volume":"342","author":"EA Taha","year":"2022","journal-title":"J Control Release"},{"issue":"22","key":"pone.0317387.ref004","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1056\/NEJMoa2504747","article-title":"Patient-specific in vivo gene editing to treat a rare genetic disease","volume":"392","author":"K Musunuru","year":"2025","journal-title":"N Engl J Med"},{"issue":"6121","key":"pone.0317387.ref005","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.1231143","article-title":"Multiplex genome engineering using CRISPR\/Cas systems","volume":"339","author":"L Cong","year":"2013","journal-title":"Science"},{"issue":"6213","key":"pone.0317387.ref006","doi-asserted-by":"crossref","first-page":"1258096","DOI":"10.1126\/science.1258096","article-title":"Genome editing. The new frontier of genome engineering with CRISPR-Cas9","volume":"346","author":"JA Doudna","year":"2014","journal-title":"Science"},{"issue":"7","key":"pone.0317387.ref007","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/s41587-020-0561-9","article-title":"Genome editing with CRISPR-Cas nucleases, base editors, transposases and prime editors","volume":"38","author":"AV Anzalone","year":"2020","journal-title":"Nat Biotechnol"},{"issue":"7681","key":"pone.0317387.ref008","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/nature24644","article-title":"Programmable base editing of A\u2022T to G\u2022C in genomic DNA without DNA cleavage","volume":"551","author":"NM Gaudelli","year":"2017","journal-title":"Nature"},{"issue":"7603","key":"pone.0317387.ref009","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nature17946","article-title":"Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage","volume":"533","author":"AC Komor","year":"2016","journal-title":"Nature"},{"issue":"8","key":"pone.0317387.ref010","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1038\/s12276-023-01057-2","article-title":"Genome editing in the treatment of ocular diseases","volume":"55","author":"EH Choi","year":"2023","journal-title":"Exp Mol Med"},{"issue":"22","key":"pone.0317387.ref011","doi-asserted-by":"crossref","first-page":"5248","DOI":"10.1111\/febs.16771","article-title":"Therapeutic applications of CRISPR\/Cas9 gene editing technology for the treatment of ocular diseases","volume":"290","author":"Y Sundaresan","year":"2023","journal-title":"FEBS J"},{"issue":"5","key":"pone.0317387.ref012","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcyt.2025.03.057","article-title":"CRISPR\/Cas9 gene editing for the retina: transient delivery using RNP in vivo and development of human retinal organoids as a model","volume":"27","author":"J Pulman","year":"2025","journal-title":"Cytotherapy"},{"issue":"4","key":"pone.0317387.ref013","doi-asserted-by":"crossref","first-page":"102349","DOI":"10.1016\/j.omtn.2024.102349","article-title":"Direct delivery of Cas9 or base editor protein and guide RNA complex enables genome editing in the retina","volume":"35","author":"J Pulman","year":"2024","journal-title":"Mol Ther Nucleic Acids"},{"issue":"11","key":"pone.0317387.ref014","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/nri1224","article-title":"Ocular immune privilege: therapeutic opportunities from an experiment of nature","volume":"3","author":"JW Streilein","year":"2003","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"pone.0317387.ref015","doi-asserted-by":"crossref","DOI":"10.1097\/IAE.0000000000002609","article-title":"Surgical technique for subretinal gene therapy in humans with inherited retinal degeneration","volume":"39","author":"JL Davis","year":"2019","journal-title":"Retina"},{"issue":"1","key":"pone.0317387.ref016","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/13816810.2021.1966053","article-title":"Stargardt disease and progress in therapeutic strategies","volume":"43","author":"D Huang","year":"2022","journal-title":"Ophthalmic Genet"},{"key":"pone.0317387.ref017","doi-asserted-by":"crossref","first-page":"108330","DOI":"10.1016\/j.exer.2020.108330","article-title":"USH2A-retinopathy: from genetics to therapeutics","volume":"201","author":"L Toualbi","year":"2020","journal-title":"Exp Eye Res"},{"issue":"2","key":"pone.0317387.ref018","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/cge.12203","article-title":"Genes and mutations causing retinitis pigmentosa","volume":"84","author":"SP Daiger","year":"2013","journal-title":"Clin Genet"},{"key":"pone.0317387.ref019","doi-asserted-by":"crossref","first-page":"1132179","DOI":"10.3389\/fnins.2023.1132179","article-title":"Rhodopsin-associated retinal dystrophy: disease mechanisms and therapeutic strategies","volume":"17","author":"F Zhen","year":"2023","journal-title":"Front Neurosci"},{"issue":"11","key":"pone.0317387.ref020","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/nbt1117-998","article-title":"First AAV gene therapy poised for landmark approval","volume":"35","author":"E Smalley","year":"2017","journal-title":"Nat Biotechnol"},{"key":"pone.0317387.ref021","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2147\/TACG.S383453","article-title":"Adeno-Associated Virus (AAV) - based gene therapies for retinal diseases: where are we?","volume":"16","author":"D Ail","year":"2023","journal-title":"Appl Clin Genet"},{"issue":"1","key":"pone.0317387.ref022","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/mt.2009.255","article-title":"Effect of genome size on AAV vector packaging","volume":"18","author":"Z Wu","year":"2010","journal-title":"Mol Ther"},{"key":"pone.0317387.ref023","doi-asserted-by":"crossref","first-page":"100915","DOI":"10.1016\/j.preteyeres.2020.100915","article-title":"Immune responses to retinal gene therapy using adeno-associated viral vectors \u2013 Implications for treatment success and safety","volume":"83","author":"K Bucher","year":"2021","journal-title":"Prog Retin Eye Res"},{"issue":"9","key":"pone.0317387.ref024","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1136\/bjophthalmol-2021-321023","article-title":"Development of retinal atrophy after subretinal gene therapy with voretigene neparvovec","volume":"107","author":"FF Reichel","year":"2023","journal-title":"Br J Ophthalmol"},{"issue":"7794","key":"pone.0317387.ref025","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/s41586-020-1978-5","article-title":"The promise and challenge of therapeutic genome editing","volume":"578","author":"JA Doudna","year":"2020","journal-title":"Nature"},{"issue":"1","key":"pone.0317387.ref026","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1186\/s12951-022-01717-x","article-title":"Nanoparticles-mediated CRISPR-Cas9 gene therapy in inherited retinal diseases: applications, challenges, and emerging opportunities","volume":"20","author":"Y Chien","year":"2022","journal-title":"J Nanobiotechnology"},{"issue":"2","key":"pone.0317387.ref027","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.add4623","article-title":"Peptide-guided lipid nanoparticles deliver mRNA to the neural retina of rodents and nonhuman primates","volume":"9","author":"M Herrera-Barrera","year":"2023","journal-title":"Sci Adv"},{"issue":"20","key":"pone.0317387.ref028","doi-asserted-by":"crossref","first-page":"12102","DOI":"10.3390\/ijms232012102","article-title":"Lipid-based nanoparticulate systems for the ocular delivery of bioactives with anti-inflammatory properties","volume":"23","author":"da Ana R","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"7","key":"pone.0317387.ref029","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/s41587-020-0491-6","article-title":"Directed evolution of adenine base editors with increased activity and therapeutic application","volume":"38","author":"NM Gaudelli","year":"2020","journal-title":"Nat Biotechnol"},{"issue":"7","key":"pone.0317387.ref030","doi-asserted-by":"crossref","first-page":"107653","DOI":"10.1016\/j.celrep.2020.107653","article-title":"Pronuclear microinjection during S-Phase increases the efficiency of CRISPR-Cas9-assisted knockin of large DNA donors in mouse zygotes","volume":"31","author":"T Abe","year":"2020","journal-title":"Cell Rep"},{"key":"pone.0317387.ref031","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12896-016-0234-4","article-title":"Efficient generation of Rosa26 knock-in mice using CRISPR\/Cas9 in C57BL\/6 zygotes","volume":"16","author":"VT Chu","year":"2016","journal-title":"BMC Biotechnol"},{"issue":"1","key":"pone.0317387.ref032","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12915-022-01227-0","article-title":"A CRISPR toolbox for generating intersectional genetic mouse models for functional, molecular, and anatomical circuit mapping","volume":"20","author":"SJ Lusk","year":"2022","journal-title":"BMC Biol"},{"key":"pone.0317387.ref033","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.fob.2015.03.003","article-title":"Insertion of sequences at the original provirus integration site of mouse ROSA26 locus using the CRISPR\/Cas9 system","volume":"5","author":"RM Quadros","year":"2015","journal-title":"FEBS Open Bio"},{"issue":"10","key":"pone.0317387.ref034","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/s41565-019-0539-2","article-title":"A biodegradable nanocapsule delivers a Cas9 ribonucleoprotein complex for in vivo genome editing","volume":"14","author":"G Chen","year":"2019","journal-title":"Nat Nanotechnol"},{"issue":"1","key":"pone.0317387.ref035","doi-asserted-by":"crossref","first-page":"8943","DOI":"10.1038\/s41598-017-09306-x","article-title":"Small molecules enhance CRISPR\/Cas9-mediated homology-directed genome editing in primary cells","volume":"7","author":"G Li","year":"2017","journal-title":"Sci Rep"},{"issue":"4","key":"pone.0317387.ref036","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0042-6989(01)00212-7","article-title":"Animal models in research on retinal degenerations: past progress and future hope","volume":"42","author":"GJ Chader","year":"2002","journal-title":"Vision Res"},{"issue":"4","key":"pone.0317387.ref037","doi-asserted-by":"crossref","first-page":"882","DOI":"10.3390\/cells9040882","article-title":"Large animal models of inherited retinal degenerations: a review","volume":"9","author":"PA Winkler","year":"2020","journal-title":"Cells"},{"key":"pone.0317387.ref038","volume-title":"Human Gene Therapy Products Incorporating Human Genome Editing","author":"Guidance for Industry","year":"2024"},{"issue":"6","key":"pone.0317387.ref039","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.ymthe.2005.08.008","article-title":"Long-term restoration of rod and cone vision by single dose rAAV-mediated gene transfer to the retina in a canine model of childhood blindness","volume":"12","author":"GM Acland","year":"2005","journal-title":"Mol Ther"},{"issue":"1","key":"pone.0317387.ref040","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/ng0501-92","article-title":"Gene therapy restores vision in a canine model of childhood blindness","volume":"28","author":"GM Acland","year":"2001","journal-title":"Nat Genet"},{"issue":"3","key":"pone.0317387.ref041","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/sj.mt.6300389","article-title":"Reversal of blindness in animal models of leber congenital amaurosis using optimized AAV2-mediated gene transfer","volume":"16","author":"J Bennicelli","year":"2008","journal-title":"Mol Ther"},{"issue":"9","key":"pone.0317387.ref042","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nbt.4172","article-title":"Improving cytidine and adenine base editors by expression optimization and ancestral reconstruction","volume":"36","author":"LW Koblan","year":"2018","journal-title":"Nat Biotechnol"},{"issue":"52","key":"pone.0317387.ref043","doi-asserted-by":"crossref","first-page":"16521","DOI":"10.1002\/anie.201707623","article-title":"evolving accelerated amidation by SpyTag\/SpyCatcher to analyze membrane dynamics","volume":"56","author":"AH Keeble","year":"2017","journal-title":"Angew Chem Int Ed Engl"},{"issue":"11","key":"pone.0317387.ref044","doi-asserted-by":"crossref","first-page":"6913","DOI":"10.1021\/acs.analchem.8b01155","article-title":"Versatile high-throughput fluorescence assay for monitoring Cas9 activity","volume":"90","author":"KJ Seamon","year":"2018","journal-title":"Anal Chem"},{"key":"pone.0317387.ref045","doi-asserted-by":"crossref","DOI":"10.1101\/2023.04.17.535579","article-title":"High-efficiency base editing for Stargardt disease in mice, non-human primates, and human retina tissue","author":"A Muller","year":"2023"},{"issue":"2","key":"pone.0317387.ref046","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nbt.3437","article-title":"Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9","volume":"34","author":"JG Doench","year":"2016","journal-title":"Nat Biotechnol"},{"issue":"6","key":"pone.0317387.ref047","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1089\/crispr.2024.0053","article-title":"Identification of a guide RNA targeting an ultraconserved element for evaluation of Cas9 genome editors across mammalian species","volume":"7","author":"BG Gowen","year":"2024","journal-title":"CRISPR J"},{"key":"pone.0317387.ref048","year":"n.d"},{"issue":"19","key":"pone.0317387.ref049","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1093\/bioinformatics\/btw354","article-title":"MultiQC: summarize analysis results for multiple tools and samples in a single report","volume":"32","author":"P Ewels","year":"2016","journal-title":"Bioinformatics"},{"issue":"3","key":"pone.0317387.ref050","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/s41587-019-0032-3","article-title":"CRISPResso2 provides accurate and rapid genome editing sequence analysis","volume":"37","author":"K Clement","year":"2019","journal-title":"Nat Biotechnol"},{"issue":"10","key":"pone.0317387.ref051","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1089\/jop.2017.0108","article-title":"The SPOTS system: an ocular scoring system optimized for use in modern preclinical drug development and toxicology","volume":"33","author":"JS Eaton","year":"2017","journal-title":"J Ocul Pharmacol Ther"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0317387","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T13:45:31Z","timestamp":1750772731000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0317387"}},"subtitle":[],"editor":[{"given":"Vahid","family":"Mansouri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,6,24]]},"references-count":51,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0317387","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.12.30.630799","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,24]]}}}